World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01783119
Date of registration: 31/01/2013
Prospective Registration: No
Primary sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Public title: Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis AVIUC
Scientific title: Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis
Date of first enrolment: August 2012
Target sample size: 60
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01783119
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment  
Phase:  Phase 0
Countries of recruitment
Mexico
Contacts
Name:     Lizzette C Alfaro
Address: 
Telephone:
Email:
Affiliation:  INCMNSZ
Name:     Jesús K Yamamoto-Furusho, MD, PhD
Address: 
Telephone: +5554870900
Email: kazuofurusho@hotmail.com
Affiliation: 
Name:     Jesús K. Yamamoto-Furusho, PhD,MD
Address: 
Telephone: +5554870900
Email: kazuofurusho@hotmail.com
Affiliation: 
Name:     Jesús K Yamamoto-Furusho, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  INCMNSZ
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with confirmed diagnosis by histopathology of Ulcerative Colitis with mild
activity level clinical, Endoscopic and histological.

- Extent of disease: pancolitis, ulcerative proctitis and left.

- Being treated with 5 - aminosalicylates (5-ASA).

- Belonging to the National Institute of Medical Sciences and Nutrition "Salvador
Zubirán".

- Signed informed consent.

Exclusion Criteria:

- Autoimmune diseases (lupus, HIV, cancer and any hepatitis).

- Another type of colitis (indeterminate, infectious drug and Crohn's Disease.

- Previous total colectomy.

- Body mass index less than 19.9 kg/m2 or greater than 40 kg/m2.

- Patients in remission histology, clinical and endoscopic.

- Under treatment with steroids, azathioprine, diuretics and anticoagulants.

- Use Aloe Vera or some natural therapy.



Age minimum: 18 Years
Age maximum: 59 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Ulcerative Colitis
Intervention(s)
Dietary Supplement: Aloe Barbadensis Miller
Dietary Supplement: placebo water
Primary Outcome(s)
Interleukine - 6 [Time Frame: 3 months]
Full Mayo Score [Time Frame: 3 months]
Secondary Outcome(s)
Secondary ID(s)
REF.589
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history